Home
/
Categories
/
Chemicals
/
Other Chemicals
/
Acute Hepato Pancreatic Necrosis Disease / Early Mortality Syndrome(AHPND/EMS) Acid Detection
Acute Hepato Pancreatic Necrosis Disease / Early Mortality Syndrome(AHPND/EMS) Acid Detection
FOB Price
Lead Time
15 working days for ready goods
China
Main Products : Detection reagent
C401, guangzhou science and technology innovation base, 80 lanyue road, science city, guangzhou econ Guangzhou, Guangdong
Acute Hepato Pancreatic Necrosis Disease / Early Mortality Syndrome(AHPND/EMS) Acid Detection Details
Brand Name
Huafeng
Model Number
Freeze-dried type
Place of Origin
China
Supply Type
In-Stock Items
Condition
New
Color
White
Acute Hepato Pancreatic Necrosis Disease / Early Mortality Syndrome(AHPND/EMS) Acid Detection Introduce

[Product Name] Acute Hepato Pancreatic Necrosis Disease / Early Mortality Syndrome(AHPND/EMS) Acid Detection

[Packaging Specification] 24 test/box Storage condition and term of validity: stored at room temperature in a cool place and away from light, valid for 12 months.

[Product Introduction] The early death syndrome of acute hepatopancreatic necrosis of prawn usually occurs in the period of 5-40 days after shrimp seedling is released, and a large number of deaths occur within a short period of time (2-5 days). The death rate can be more than 90 percent. Based on the pcr-fluorescence probe nucleic acid amplification technology, this product amplifies and detects the specific gene fragment of the pathogen of acute hepatopancreatic necrosis (AHPND/EMS) in prawn under experimental conditions, and optimizes the reaction system for various samples, so that accurate detection results can be obtained in a short time.

roduct Rapid detection: PCR amplification wHigh specificity: using TaqMan probe as qPCR detection reagent, high specificity.

Easy to use: one tube freeze-drying, eliminating the cumbersome solution configuration steps.